-
Pharmacists in Florida Must Warn Patients About Certain Drug Risks
Appellate Court Imposes New Legal Duty on Florida Pharmacists In early June 2005 a Florida appellate court ruled that a Florida pharmacist can be held legally liable for failing to warn patients about certain…
-
Tysabri: Will this Multiple Sclerosis Drug Return to U.S. Market or Not?
Fourth Case of Tysabri-related PML is Reported to FDA by Manufacturer A fourth patient taking the multiple sclerosis drug Tysabri may have contracted a deadly brain disease called progressive multifocal leukoencephalopathy, or PML, calling…
-
FDA Announces Recall of All Drugs from Able Laboratories
All Able Laboratories Drugs Recalled Due to Production Quality Concerns On June 1, 2005 the FDA announced that the agency has issued a nationwide recall of all drugs — mostly generic prescription drugs, including…
-
Drug Manufacturers Exploring Way to “Spy” on Blogs and Other Internet Postings
Internet Spying by Drug Companies Said to be "for the good of the patient" On May 30, 2005 the Financial Times (London, UK) newspaper reported that drug manufacturers GlaxoSmithKline, Pfizer, and Johnson & Johnson…
-
David Graham Speaks at May 2005 Event About Need for Change at FDA
FDA was "the single greatest obstacle" as to Vioxx Withdrawal David Graham says the FDA, itself, was the "single greatest obstacle to doing anything effective" about getting the unsafe prescription drug Vioxx withdrawn from…
-
Natrecor Given Regularly to Outpatients is Focus of Current Safety Controversy
In May 2005 Scios Sent a Natrecor "Dear Doctor" Letter to Heart Doctors Natrecor is a prescription drug approved by the FDA as a therapy for hospitalized patients or those rushed to emergency rooms…
